NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS Conference

Wefel, Jeffrey, Pugh, Stephanie, Choucair, Ali et al. (2019). NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS . NEURO-ONCOLOGY, 21 158-159.

International Collaboration

cited authors

  • Wefel, Jeffrey; Pugh, Stephanie; Choucair, Ali; Fisher, Barbara; Fox, Sherry; Meyers, Christina; Ashby, Lynn; Mikkelsen, Tom; Glass, Jon; Yu, Michael; Howard, Steven; Movsas, Benjamin; Mehta, Minesh

sustainable development goals

authors

date/time interval

  • November 20, 2019 -

publication date

  • November 1, 2019

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • AZ, Phoenix

Conference

  • 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

publisher

  • OXFORD UNIV PRESS INC

start page

  • 158

end page

  • 159

volume

  • 21